Propyphenazone is a provolone derivative with an analgesic and antipyretic effect.
As a non-steroid anti-inflammatory drug, an unselective SOH inhibitor, it acts by inhibiting the prostaglandin synthesis, thus achieving its analgesic effect. The antipyretic effect is a result of its central action on the thermoregulation centre, that is, it decreases the elevated body temperature.
The recommended daily doses are 300-1000 mg. The maximum daily dose is 900 mg – 4 g, which is 19 times higher than the dose contained in one Caffetin® tablet. The recommended dose for children is 300 mg; the maximum dose for children is 1200 mg.
One Caffetin® tablet contains only 210 mg propyphenazone.